A new Crispr-powered optical blood test detects lung cancer biomarkers at sub-attomolar levels, offering earlier molecular detection than conventional PCR or imaging.
Private companies are capitalizing on this quest for information. Grail’s Galleri blood test screens for more than 50 ...
Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...
Blood tests are helpful for monitoring your overall health. But research suggests they can also give us clues about the ...
PALO ALTO, Calif., Dec. 5, 2025 /PRNewswire/ -- DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, announced ...
A new light-based sensor detects cancer markers at near-zero concentrations.
Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study Data ...
But whether patients should be getting the tests—as some already are—is not yet clear. New blood tests can detect cancer recurrence earlier than traditional scans, potentially giving doctors and ...
February 2026 coverage highlighted combination EGFR therapy guidance, chemo-free treatment options, biomarker testing and survivorship lung health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results